Skip to content

Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine

C22H29N5 — CID 159953415

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine
SMILESC.CCCCN(C)Cc1ccc2[nH]c(-c3ccnc4nc(C)[nH]c34)cc2c1
InChIInChI=1S/C21H25N5.CH4/c1-4-5-10-26(3)13-15-6-7-18-16(11-15)12-19(25-18)17-8-9-22-21-20(17)23-14(2)24-21;/h6-9,11-12,25H,4-5,10,13H2,1-3H3,(H,22,23,24);1H4
InChIKeyOCKGSMKHOXQOIF-UHFFFAOYSA-N
MW363.51 g/mol
LogP5.28
Rot. Bonds6

About Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine

Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine (PubChem CID 159953415) has the molecular formula C22H29N5 and a molecular weight of 363.51 g/mol. Its IUPAC name is methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine.

Molecular Properties

Compound NameMethane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine
PubChem CID159953415
Molecular FormulaC22H29N5
Molecular Weight363.51 g/mol
Exact Mass363.24
IUPAC Namemethane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine
SMILESC.CCCCN(C)Cc1ccc2[nH]c(-c3ccnc4nc(C)[nH]c34)cc2c1
InChIInChI=1S/C21H25N5.CH4/c1-4-5-10-26(3)13-15-6-7-18-16(11-15)12-19(25-18)17-8-9-22-21-20(17)23-14(2)24-21;/h6-9,11-12,25H,4-5,10,13H2,1-3H3,(H,22,23,24);1H4
InChIKeyOCKGSMKHOXQOIF-UHFFFAOYSA-N
XLogP5.28
TPSA60.60 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms27
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500363.51
LogP ≤ 55.28
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine?
The IUPAC name of Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine (CID 159953415) is methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine.
What is the SMILES notation for Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine?
The canonical SMILES for Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine is C.CCCCN(C)Cc1ccc2[nH]c(-c3ccnc4nc(C)[nH]c34)cc2c1.
What is the InChIKey of Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine?
The InChIKey is OCKGSMKHOXQOIF-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N5.CH4/c1-4-5-10-26(3)13-15-6-7-18-16(11-15)12-19(25-18)17-8-9-22-21-20(17)23-14(2)24-21;/h6-9,11-12,25H,4-5,10,13H2,1-3H3,(H,22,23,24);1H4.
What are the key properties of Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine?
Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine has a molecular weight of 363.51 g/mol, XLogP of 5.28, 6 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for Methane;N-methyl-N-[[2-(2-methyl-1H-imidazo[4,5-b]pyridin-7-yl)-1H-indol-5-yl]methyl]butan-1-amine is sourced from PubChem (CID 159953415), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.